Overall Technical outlook

Price Summary

2025-07-14, saw SUVENPHAR's stock open at 1017.95, hit a peak of 1035.0, fall to a low of 995.0, and close up 1.31% at 1031.25, with 201430 shares changing hands.
Over the course of 52 weeks, the stock peaked at 1334.2 and hit a low of 820.6.
The future price of SUVENPHAR is anticipated to range from 1290.0 to 1500.0, with an expected mean price of 1396.6666, according to the recommendations of 6 analysts.

Technicals

Support and Resistance: At 1031.25, the price is supported by 975.3 and resisted by 1048.2. This indicates that the price for Suven Pharmaceuticals Limited might fluctuate between these levels, with 975.3 acting as a support and 1048.2 limiting further upward movement.
SUVENPHAR supportResistance 264a3a
Support/Resistance for SUVENPHAR


Aroon: The AROON is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
SUVENPHAR aroon 264a3a
Aroon chart for Suven Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is currently in a neutral position for Suven Pharmaceuticals Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
SUVENPHAR bbands 264a3a
Bolinger Bands chart for Suven Pharmaceuticals Limited


Parabolic SAR: The PSAR continues to indicate a bullish outlook, establishing a key support level that could sustain the market's upward trend. This support suggests that the bullish momentum is likely to persist, offering a foundation for further growth.
SUVENPHAR psar 264a3a
Parabolic Stop and Reverse chart for Suven Pharmaceuticals Limited


Stochastic: The current state of the STOCHASTIC is neutral for SUVENPHAR, providing no clear indication of a trend in either direction. This suggests that the market may be lacking momentum, making it difficult to predict future movements.
SUVENPHAR stoch 264a3a
Stochastic chart for Suven Pharmaceuticals Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
SUVENPHAR trippleSMA 264a3a
Tripple SMA chart for Suven Pharmaceuticals Limited


When analyzing a company, its fundamentals—such as earnings, management efficiency, and strategic initiatives—must be considered alongside technical data. The context of the industry in which the company operates also plays a key role, as market trends and competitive dynamics can significantly impact performance. By taking a comprehensive approach, combining both fundamental and technical analysis, one can gain a deeper understanding of the company's potential for growth or risk.